New Alzheimer’s drug Aducanumab – cost, side effects, timeline and other questions answered
Patients and their families are starting to inquire about the new Alzheimer’s drug approved this week by the US Food and Drug Administration.
Shipments of the medication are expected to go out in just a couple of weeks. Hospitals are on tap to administer treatment when needed. And there is serious division in the FDA, especially around the drug’s effectiveness.
Aducanumab, to be sold under the brand name Aduhelm, was approved to treat patients with Alzheimer’s disease against the recommendation of an FDA advisory committee that concluded last year there is not enough evidence to support approval of the treatment. The FDA has not approved a novel therapy for Alzheimer’s disease since 2003.
New Alzheimer’s drug aducanumab: cost, side effects, timeline and other questions answered
Patients and their families are starting to inquire about the new Alzheimer’s drug approved this week by the US Food and Drug Administration.
Shipments of the medication are expected to go out in just a couple of weeks. Hospitals are on tap to administer treatment when needed. And there is serious division in the FDA, especially around the drug’s effectiveness.
Aducanumab, to be sold under the brand name Aduhelm, was approved to treat patients with Alzheimer’s disease against the recommendation of an FDA advisory committee that concluded last year there is not enough evidence to support approval of the treatment. The FDA has not approved a novel therapy for Alzheimer’s disease since 2003.
【認知障礙症】阿茲海默症新藥可延緩退化？臨牀測試成效參差副作用嚴重惹關注（附:阿茲海默症知多點） mingpao.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mingpao.com Daily Mail and Mail on Sunday newspapers.